In.Pact Av
Payments companies reported to CMS as associated with In.Pact Av. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with In.Pact Av, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with In.Pact Av
These are the largest totals companies reported as associated with In.Pact Av. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ari Kramer | Spartanburg, SC | Surgery | $20,991.08 |
| Rashid Sharaf | San Antonio, TX | Nephrology (Internal Medicine) | $5,165.26 |
| Rishi Razdan | Jacksonville, FL | Vascular & Interventional Radiology | $3,965.26 |
| Haimanot Wasse | Atlanta, GA | Nephrology (Internal Medicine) | $3,060.37 |
| Adrian Sequeira | Shreveport, LA | Nephrology (Internal Medicine) | $3,023.96 |
| Dalia Zaky Dawoud | Riverside, CA | Nephrology (Internal Medicine) | $3,000.00 |
| Robert Minor | Billings, MT | Interventional Cardiology | $1,600.00 |
| Vincent Gallo | Teaneck, NJ | Vascular & Interventional Radiology | $1,465.27 |
| Paul Kreienberg | Albany, NY | Vascular Surgery | $1,222.81 |
| Ajit Rao | New York, NY | Vascular Surgery | $1,110.05 |
Prescribed In.Pact Av?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.